-
Constantine Si Lun Tam, MBBS, MD Peter MacCallum Cancer Centre University of Melbourne 5Live #ASCO20
1:43
Key Insights on Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib
-
Constantine Si Lun Tam, MBBS, MD Peter MacCallum Cancer Centre University of Melbourne 5Live #ASCO20
5:54
"Key Insights on ASPEN: Results of a phase III randomized trial of zanubrutinib versus ibrutinib for patients with Waldenström macroglobulinemia (WM) "
